4//SEC Filing
Hoey Timothy 4
Accession 0000950170-24-018222
CIK 0001858848other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 6:05 PM ET
Size
7.4 KB
Accession
0000950170-24-018222
Insider Transaction Report
Form 4
Hoey Timothy
Chief Scientific Officer
Transactions
- Sale
Common Stock
2024-02-20$6.17/sh−200$1,233→ 236,146 total - Sale
Common Stock
2024-02-20$5.31/sh−6,369$33,813→ 236,346 total
Footnotes (4)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2023.
- [F2]Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $5.13 to $6.07. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]Includes 37,500 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- [F4]Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $6.16 to $6.17. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
Tenaya Therapeutics, Inc.
CIK 0001858848
Entity typeother
Related Parties
1- filerCIK 0001553333
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 6:05 PM ET
- Size
- 7.4 KB